thermo fisher deliv in-lin result maintain
updat forecast estim oct
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research oct
estim oct
price data jan
rate updat jan
currenc amount express
valuat growth profit
methodolog valu compani
bigger alway better thermo fisher nonetheless
maintain torrid pace acquisit ultim goal
becom go-to provid life scienc instrument
consum recent firm acquir affymetrix
fei announc billion acquisit patheon
remain cautiou regard firm growth-via-acquisit
strategi yet see evid billion
compani spent acquisit sinc yield
benefit return invest capit
acquisit strategi allow firm significantli
broaden product offer turn allow steadili
gain market share one-stop shop approach afford price
flexibl result strong custom relationship
compani find recept audienc larg pharma client
see sizabl benefit simplifi procur process
thermo fisher offer result firm penetr pharma
expand expect continu even see
deceler biopharma spend growth
thermo fisher emerging-market presenc also impress
grow
manufactur footprint area allow compet
effect indigen manufactur brand carri
great power among research given on-going
commit research
life scienc
emerging-market govern compani goal expand
emerging-market busi annual appear
firm effort yield organ market share gain
core strategi remain growth acquisit
aggress clearli state capital-deploy strategi
remain risk firm could overpay yet anoth sizabl
deal fuel cheap financ said ever-expand
presenc virtual area life scienc research part
achiev acquisit afford thermo fisher opportun
capit strong secular growth expect sector
next decad
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
thermo fisher scientif sell scientif instrument laboratori
equip diagnost consum life scienc reagent firm
oper four segment analyt technolog
sale fei acquisit specialti diagnost product life
scienc solut includ affymetrix lab product servic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
rais full-year guidanc
revenu earn line larg driven
slight out-performance third quarter
slightli adjust number enough result
chang fair valu estim narrow moat
rate also intact share look fairli valu current
demand pharma custom base deceler
midsingl digit compani line peer
long-term project howev firm get
momentum channel name academia
industri support overal organ growth
quarter still see pharma biotech demand
main growth driver thermo fisher note mid-
single-digit growth past quarter partli affect
discontinu larg clinic trial fourth-
quarter sit top robust number
suggest compani continu gain share
channel particularli evid among larg custom
thermo fisher value-add highest
academia growth midsingl digit europ
offset cautiou approach custom
still seemingli affect uncertainti surround
govern spend budget
segment analyt instrument standout
quarter mid- high singl digit adjust fei fei
continu deliv unexpect level perform
anoth double-digit growth rate quarter alreadi
justifi price paid busi
turnaround quit remark excel
perform end market sinc acquisit albeit
help
semiconductor channel mass spec lc also deliv
healthi result quarter segment start
overal
see increas activ chemic environment
channel posit nice
valuat growth profit jun
rais fair valu estim per share
due mainli cash flow realiz sinc previou
report also slightli modifi tax rate go forward
includ patheon acquisit assumpt
account currenc headwind revenu
organ growth expect core busi
approxim firm continu see
steadi growth biopharma spend stabl demand
academ govern custom particularli
unit state improv perform industri
end market long-term expect double-digit
growth emerg market need off-set much
matur inflationlik growth develop world
anticip modest benefit acquisit
long term forecast thermo fisher sale
increas approxim per year organ
firm like resum acquisit strategi
deleverag expect analyt instrument life
scienc segment drive futur growth matur
catalog busi provid cash flow fund
invest growth area anticip thermo fisher
adjust oper margin exclud amort
improv basi point next five year line
firm
manufactur shift lower-cost region effici
improv off-set price pressur
mani commod product
believ thermo fisher deliv acquisit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
analyt diagnost busi low-single-digit
growth laboratori segment assumpt
fairli conserv given
macroeconom
environ europ particular hesit
incorpor aggress assumpt
mid-single-digit growth develop market china
deliv double-digit growth throughout forecast
signific upsid valuat posit scenario
valu compani per share
integr expect thu base-cas scenario
incorpor compani synergi forecast much
million cost save ultim much
uncertainti surround fair valu estim pertain
amount synergi well success
anticip life busi grow averag
forecast period growth acceler toward
latter year forecast potenti
compani continu see slow uptick
developed-world demand china deceler fair
valu estim fall per share thermo fisher
knack cost control challeng growth environ
also propens supplement intern growth
acquisit henc growth environ remain
constrain compani could opt becom aggress
acquisit front provid addit risk
speed magnitud recoveri industri
end market also one key variabl underli
assumpt thermo fisher expect
mid-single-digit organ revenu growth firm
thermo fisher narrow moat come scale
scope busi -- enorm manufactur sale
infrastructur along broad product
offer rang scientif instrument lab
equip softwar servic steadi consolid
variou busi
instrument fisher catalog phadia dionex
life affymetrix fei pend patheon acquisit
allow compani market one-stop shop
research custom appeal featur
laboratori look simplifi procur function
addit life compani consum busi
even massiv entrench custom base
autom inventori manag across broad array
product strong sell point compani
compani access custom channel unparallel
legaci fisher catalog domin marketplac
next-largest competitor significantli
smaller presenc also afford firm massiv
cross-sel opportun thermo fisher salesforc
also far largest industri allow
compani penetr emerg market final
distribut network give firm unmatch scale
thermo fisher also domin posit within
signific switch cost result costli
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
up-front invest equip exceed
million train instal instrument
requir recur stream consum purchas
servic revenu therebi insul thermo fisher
full brunt capit cycl competitor pressur
hesit award thermo fisher wide econom moat
larg lack confid compani abil
persist gener return invest capit
excess cost primarili owe acquisit strategi
opt includ acquisit associ goodwil
assumpt
on-going capit deploy
requir compani use acquisit
supplement intern research develop
deal size grow larger thermo fisher increasingli
face scenario deploy capit value-dilut
manner particularli interest rate increas
thermo fisher moat widen compani
low-cost posit rais
custom compani
distribut network alreadi far largest
offer scale advantag competit continu
grow rapidli particularli low-cost manufactur
area compani strong on-the-ground presenc
china coupl alreadi well-establish bond
multi-national compani expand
market allow capit market
rapid growth also cement tight relationship
custom unlik larg instrument maker
larger compani instal base stronger
competit advantag equip busi due
switch cost high-margin recur revenu stream
final increas abil offer custom
complet solut procur need allow
thermo fisher squeez smaller peer even gain
ground larger organ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
oth firm target market approxim billion
fisher largest supplier research instrument
consum
aggress acquir
compani expans strategi depend heavili
success acquisit earn number
pollut signific non-gaap adjust
othermo fisher among industri leader nearli
ubiquit research lab across globe
addit effici integr acquir
busi compani invest heavili
technolog particularli mass spectrometri
one global leader
firm diagnost busi struggl
gener momentum legaci phadia
busi strong foothold europ
growth impress
oth compani abl fuel acquisit spree via
access extrem inexpens debt gener
excess return acquisit less favor
interest rate environ might challeng
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
end thermo fisher carri billion long-
short-term debt time ebitda held
million cash balanc sheet acquisit
fei affymetrix delay manag goal
achiev target leverag time within
month complet acquisit
solvenc concern limit manag state
past would will boost debt leverag
time right opportun given current
size could give enough flexibl complet deal
compar fei decemb major matur
next five year includ commerci paper
borrow million million senior note due
billion two tranch due
compani gener robust cash flow concern
regard solvenc minim furthermor
compani cash flow rather predict
consum servic account major
total sale anticip thermo fisher remain
aggress acquisit share buyback
compani pay dividend rather small rel
free cash flow forecast includ billion
pend acquisit patheon thermo fisher plan
financ acquisit billion new equiti
remaind debt deal postpon
de-lever strategi compani
issu get target level assum deal
life scale next year two
firm exposur industri end market increas
vulner prolong secular downturn
market -- china india -- cut back environment
qualiti test due fiscal concern currenc headwind
could off-set thermo recoveri life
scienc market compani face tough competit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
analyt instrument busi particularli
research activ academia govern
could advers affect delay fund
feder nation institut busi
signific risk technolog nascent final
acquisit strategi continu expos firm risk
overpay inabl integr acquir busi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
believ manag team perform
ultim judg success acquisit
strategi yet produc meaning return
invest capit access cheap financ fuel
recent buy spree interest see whether
chase earn per share growth backfir rate
eventu rise think manag team fare
well integr numer acquisit deploy
cash flow value-accret way success
integr sizabl fairli expens purchas life
signific challeng marc casper team
compani suggest return capit metric
discuss frequent late improv
next five year howev chronic acquisit make
promis rather murki see opportun
continu drive margin improv intern
improv synergi ignor dilut
impact acquisit believ continu
return compani emphasi adjust ep
obscur realiti acquisit play role
repres date owner name posit common share held report holder issuer
va collegeamerica growth fund america
fidel manag research compani
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
year forecast
thermo fisher deliv as-expect result
rais full-year guidanc
revenu earn line larg driven
favour currenc adjust slightli
number enough result chang fair
valu estim narrow moat rate also intact
share look fairli valu current level
pharma custom base remain best-perform
end market thermo fisher second quarter
similar peer growth deceler
midsingl high singl digit compani note
advers event affect rate pharma
clinic trial cancel even cancel
see sequenti slowdown growth said
still consid level demand healthi -- two-year
stack growth rate close doubl digit -- impli
moder second part year
academia growth low singl digit still
seemingli affect
uncertainti surround
govern spend unit state
nation institut budget upcom year
healthi still concern regard end market
particularli given gener sentiment toward
non-discretionary spend trump administr
howev thermo fisher gener fare better
peer industri appli market well asia
deliv robust growth china midteen
quarter pharma research emerg strong
growth engin region
remain impress compani abil expand
oper margin execut anoth
basi point margin expans quarter
model basi point margin expans full
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
equival
net properti plant equip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
